This study examined the impact of a pregabalin step therapy policy on utilization and medical costs in Humana’s Medicare and commercial plans.
Margaret K. Pasquale, PhD
Advertisement
Articles by Margaret K. Pasquale, PhD
This study developed and tested predictive models of opioid abuse using Humana commercial membership data that were subsequently tested in the Truven commercial data set.
Advertisement
Latest Updated Articles
- Understanding Predictors of Opioid Abuse: Predictive Model Development and Validation
Published: October 21st 2014 | Updated:
- Trends Associated with Implementing and Lifting a Pregabalin Step Therapy Policy
Published: April 19th 2016 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Estradiol-Containing MHT May Impact Alzheimer Disease-Related Biomarkers in Postmenopausal Women
2
CHEST 2025: Exploring the Link Between GLP-1 Receptor Agonists, Type 2 Diabetes, and Asthma Risk
3
Axatilimab: A New Frontier for Steroid-Refractory Chronic GVHD
4
World Standards Week 2025: Advancing Quality and Patient Safety Standards to Shape Pharmacy Practice and Innovation
5
